peginterferon plus ribavirin and glutamine therapy against chronic hepatitis C
Phase 1
Recruiting
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000003865
- Lead Sponsor
- Osaka Prefectural General Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
liver cirrhosis autoimmune hepatitis primary biliary cirrhosis malignancy depression drug abuse pregnant or lactating woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained virological response or non-response
- Secondary Outcome Measures
Name Time Method Safety